The right dose for every patient: a key step for precision medicine
Author:
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Link
http://www.nature.com/articles/nrd.2015.22.pdf
Reference5 articles.
1. Bel, E. H. et al. Oral glucocorticoid sparing effect of mepolizumab in eosinophilic asthma. N. Engl. J. Med. 371, 1189–1197 (2014).
2. Yang, J. et al. The combination of exposure-response and case-control analyses in regulatory decision making. J. Clin. Pharmacol. 52, 160–166 (2012).
3. Wang, J. et al. Exposure–response relationship of T-DM1: insight into dose optimization for patients with HER2-positive metastatic breast cancer. Clin. Pharm. Ther. 95, 558–564 (2014).
4. Ohtsu, A. et al. Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized double-blind, placebo-controlled phase III study. J. Clin. Oncol. 29, 3968–3976 (2011).
5. Grahnen, A. & Karlsson, M. O. Concentration-controlled or effect-controlled clinical trials. Useful alternatives to conventional dose-controlled trials? Clin. Pharmacokinet. 40, 317–325 (2001).
Cited by 49 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The Convergence of Radiology and Genomics: Advancing Breast Cancer Diagnosis with Radiogenomics;Cancers;2024-03-06
2. Beyond Population‐Level Targets for Drug Concentrations: Precision Dosing Needs Individual‐Level Targets that Include Superior Biomarkers of Drug Responses;Clinical Pharmacology & Therapeutics;2024-02-08
3. Binder jetting 3D printing in fabricating pharmaceutical solid products for precision medicine;Basic & Clinical Pharmacology & Toxicology;2024-01-19
4. Genomics in Clinical trials for Breast Cancer;Briefings in Functional Genomics;2023-12-23
5. DICTrank: The largest reference list of 1318 human drugs ranked by risk of drug-induced cardiotoxicity using FDA labeling;Drug Discovery Today;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3